According to Fortune Business Insights, the global Hospital Acquired Infection Control Market size was valued at USD 22.88 billion in 2025. The market is projected to grow from USD 24.44 billion in 2026 to USD 41.34 billion by 2034, exhibiting a CAGR of 6.79% during the forecast period (2026–2034). North America dominated the global market with a 39% revenue share in 2025, supported by advanced healthcare infrastructure, increasing investments in infection prevention technologies, and stringent hospital hygiene requirements.
Market Overview
The Hospital Acquired Infection Control Market includes equipment, consumables, and specialized services designed to prevent, monitor, and control infections within healthcare environments.
Major products include sterilization systems, washer-disinfectors, endoscope reprocessors, antimicrobial products, protective barriers, and infection monitoring technologies.
Increasing demand for reliable infection prevention solutions is encouraging hospitals to modernize their sterilization infrastructure.
Healthcare facilities are also adopting integrated infection control programs that combine equipment monitoring, staff training, environmental disinfection, and digital surveillance.
However, high equipment costs, maintenance requirements, and inconsistent compliance with infection prevention procedures remain significant challenges.
For detailed market insights: https://www.fortunebusinessinsights.com/hospital-acquired-infection-control-market-116150
Hospital Acquired Infection Control Market Trends
Increasing Adoption of Automated Sterilization Technologies
One of the major Hospital Acquired Infection Control Market trends is the growing adoption of automated sterilization and disinfection equipment.
Hospitals are implementing robotic disinfection systems, ultraviolet-C technologies, and automated washer-disinfectors to improve sterilization consistency.
These technologies reduce manual intervention and support efficient infection prevention workflows.
Growing Demand for Low-Temperature Sterilization
Low-temperature sterilization technologies are gaining importance as healthcare facilities increasingly use heat-sensitive surgical instruments and advanced endoscopic devices.
Vaporized hydrogen peroxide and gas-plasma sterilization systems help process delicate medical equipment without exposing it to conventional high-temperature sterilization conditions.
Integration of Digital Infection Surveillance
Healthcare organizations are increasingly adopting digital infection monitoring platforms.
These systems centralize infection-related information, track compliance, and support faster identification of potential infection risks.
Connected sterilizers, sensor-based hand hygiene monitoring, and automated reporting technologies are becoming important components of modern infection prevention programs.
Hospital Acquired Infection Control Market Drivers
Rising Prevalence of Healthcare-Associated Infections
The increasing need to prevent healthcare-associated infections is a major factor driving Hospital Acquired Infection Control Market growth.
Patients undergoing surgery, catheterization, mechanical ventilation, dialysis, and other invasive procedures face greater infection risks.
Healthcare providers are strengthening sterilization, environmental cleaning, and protective equipment practices to reduce infection transmission.
Increasing Surgical Procedures and Hospital Admissions
Growing surgical volumes and expanding healthcare services are supporting demand for infection control equipment.
Hospitals require reliable sterilization systems to process reusable surgical instruments and maintain hygienic operating environments.
The increasing geriatric population and prevalence of chronic diseases are also contributing to healthcare utilization.
Growing Concerns About Antimicrobial Resistance
The emergence of antimicrobial-resistant microorganisms is encouraging healthcare organizations to strengthen infection surveillance and environmental controls.
Advanced disinfection technologies, antimicrobial surfaces, and protective consumables are becoming essential components of comprehensive infection prevention strategies.
Hospital Acquired Infection Control Market Segmentation
The global market is segmented by type, end use, and geography.
By Type
Equipment: The equipment segment dominated the market with approximately 38% share. It includes sterilizers, washer-disinfectors, endoscope reprocessors, ultraviolet disinfection systems, and microbial testing equipment.
Services: The services segment accounted for approximately 29% market share. It includes sterilization validation, equipment maintenance, infection control consulting, staff training, and environmental disinfection services.
Consumables: The consumables segment represented approximately 33% market share. Products include disinfectants, gloves, gowns, masks, sterilization wraps, wipes, and biological indicators.
By End Use
Hospitals & ICUs: The hospitals and intensive care units segment dominated with approximately 72% market share.
High patient volumes, complex surgical procedures, critical care requirements, and prolonged hospital stays contribute to strong demand.
Ambulatory Surgical and Diagnostic Centers: This segment accounted for approximately 28% market share.
Increasing outpatient procedures and demand for compact sterilization systems are supporting segment expansion.
Key Players in the Hospital Acquired Infection Control Market
Major companies operating in the global market include:
3M
Belimed Inc.
O&M Halyards
Getinge
ASP (Advanced Sterilization Products Services, Inc.)
Sterigenics U.S., LLC - A Sotera Health Company
MMM Group
Midmark Corporation
STERIS
W&H
According to the report, STERIS holds approximately 9% market share, followed by Getinge with approximately 8%.
These companies are focusing on advanced sterilization technologies, product innovation, digital monitoring, and strategic partnerships to strengthen their competitive positions.
Hospital Acquired Infection Control Market Regional Analysis
North America
North America dominated the global Hospital Acquired Infection Control Market with approximately 39% market share in 2025.
The region benefits from advanced healthcare infrastructure, strong infection prevention programs, and widespread adoption of sophisticated sterilization technologies.
The United States represents the majority of regional demand, supported by hospital modernization and investments in infection surveillance.
Europe
Europe accounted for approximately 27% of the global market.
Stringent infection control standards, established healthcare systems, and increasing adoption of environmentally responsible sterilization technologies support regional growth.
Germany represents approximately 31% of Europe's market, while the United Kingdom accounts for approximately 24%.
Asia Pacific
Asia Pacific held approximately 24% market share, supported by expanding healthcare infrastructure and increasing surgical procedures.
China, Japan, India, and Southeast Asian countries are investing in hospital modernization and advanced infection prevention technologies.
China accounts for approximately 35% of the regional market, followed by Japan with approximately 31%.
Rest of the World
The Rest of the World region, including Latin America, the Middle East, and Africa, represented approximately 10% market share.
Growing investments in hospitals, surgical facilities, and essential sterilization infrastructure are creating new opportunities for infection control manufacturers.
Competitive Landscape
The Hospital Acquired Infection Control Market features competition among established medical technology manufacturers, sterilization equipment suppliers, and specialized infection prevention service providers.
Leading companies are investing in automation, low-temperature sterilization, digital connectivity, and environmentally sustainable products.
Recent developments highlighted in the report include:
2023: ASP expanded its steam sterilization monitoring portfolio with BIOTRACE biological indicators and other monitoring products.
2024: Getinge introduced the Poladus 150 vaporized hydrogen peroxide low-temperature sterilizer.
2024: ASP introduced the ULTRA GI Cycle for its STERRAD 100NX Sterilizer.
2024: Midmark launched next-generation M11 and M9 steam sterilizers.
2025: ASP expanded its rapid biological indicator technologies.
These innovations demonstrate the industry's increasing emphasis on sterilization reliability, operational efficiency, and infection prevention.
Future Outlook
The global Hospital Acquired Infection Control Market is expected to experience sustained growth through 2034 as healthcare organizations continue strengthening infection prevention infrastructure.
Increasing adoption of automated sterilizers, robotic disinfection systems, and digital monitoring platforms will create opportunities for manufacturers.
Future innovations are expected to focus on faster sterilization processes, improved equipment connectivity, low-temperature technologies, and sustainable infection control products.
Emerging healthcare markets will also provide opportunities as hospitals expand surgical capacity and modernize medical facilities.
Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hospital-acquired-infection-control-market-116150
Conclusion
The global Hospital Acquired Infection Control Market is positioned for steady expansion, supported by increasing healthcare-associated infection concerns, rising surgical procedures, and technological advancements in sterilization equipment.
With the market projected to reach USD 41.34 billion by 2034, manufacturers are expected to prioritize automation, infection surveillance, and advanced disinfection technologies.
North America is anticipated to maintain its leading position, while Asia Pacific offers significant opportunities through healthcare infrastructure development.
Latest 5 Trending FAQs
1. How big is the Hospital Acquired Infection Control Market?
Fortune Business Insights says that the global market value stood at USD 22.88 billion in 2025 and is projected to reach USD 41.34 billion by 2034.
2. At what CAGR is the market projected to grow during the forecast period of 2026–2034?
The market is expected to exhibit a CAGR of 6.79% during the forecast period of 2026–2034.
3. Which was the leading application/type segment in the market?
Hospitals and intensive care units dominated the end-use segment with approximately 72% market share, driven by high patient volumes, complex surgical procedures, and increased infection prevention requirements.
4. Who are the top players in the Hospital Acquired Infection Control Market?
Major players include 3M, Belimed Inc., O&M Halyards, Getinge, ASP (Advanced Sterilization Products Services, Inc.), and Sterigenics U.S., LLC - A Sotera Health Company.
5. What are the major trends driving the Hospital Acquired Infection Control Market?
Major trends include increasing adoption of automated sterilization equipment, robotic and UV-C disinfection systems, low-temperature sterilization technologies, digital infection surveillance, and environmentally sustainable infection prevention products.
What Everyone Should Know About Japan’s Market Hospital Acquired Infection Control Market Insights